SCHEMBL29316442

SCHEMBL29316442

CC(C)OC1CCC(CCC(C)N2CCC(C(C)C)CC2)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26745407 0.86 HRH3 (0.31) —
SCHEMBL26745413 0.86 HRH3 (0.31) —
SCHEMBL26742133 0.86 HRH3 (0.31) —
SCHEMBL29322928 0.81 OPRM1 (0.33) —
SCHEMBL26746306 0.78 HRH3 (0.30) —
SCHEMBL26746302 0.78 HRH3 (0.30) —
SCHEMBL26752716 0.78 HRH3 (0.30) —
SCHEMBL26752719 0.78 HRH3 (0.30) —
SCHEMBL26746297 0.78 HRH3 (0.30) —
SCHEMBL26256353 0.78 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240238423-A9 TETRAHYDROISOQUINOLINE HETEROBIFUNCTIONAL BCL-XL DEGRADERS Treeline Biosciences, Inc. 2024-07-18 — — US disclosed
Send feedback